Through these pathways, Lp-PLA2 is implicated in a range of diseases, including atherosclerosis, diabetes, Alzheimer's disease, cancer, autoimmune disorders, and inflammation associated with infections. This evidence concerns the gene PLA2G7 and diabetes mellitus.